#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fungal infection Methylmalonic acidaemia Neoplasm malignant Small intestine neuroendocrine tumour Carcinoid tumour Neuropathy peripheral Pulmonary fibrosis Osteosarcoma Activated PI3 kinase delta syndrome Acute myeloid leukaemia (in remission) Staphylococcal infection Transferrin decreased Mantle cell lymphoma stage II Central nervous system neoplasm Adenocarcinoma pancreas More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Treatment Burkitt’s lymphoma – Diagnostics Cystic fibrosis – Life with Disease Ocular melanoma – Basic Information Rhabdoid tumour – Treatment Pleural mesothelioma malignant Methylmalonic acidaemia – Trials in Disease Von Willebrand’s disease Glycogen storage disease type I – Treatment Pleomorphic leiomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SAROGLITAZAR HEMIMAGNESIUM Dabigatran Etexilate Eliglustat Tartrate Imiglucerase M2Rlab Ertapenem Sodium Napabucasin Valproate Semisodium Poa Pratensis Tas3351 Metolazone Etifoxine Hydrochloride Ademetionine Amoxicillin Trihydrate Amoxicillin Sodium Immunoglobulins, Normal Human Cefixime Vorasidenib RNMB2 Gallium (68Ga) More therapies…

    Learn about Your Condition

    Heparin resistance Vertebrobasilar stroke Drug eruption Genital herpes simplex Malignant melanoma stage II Infertility male Postprandial hypoglycaemia Adrenogenital syndrome Epileptic encephalopathy Neuroblastoma Sciatica Renal transplant Glucose tolerance impaired Periodontitis Pharyngeal cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Sar444656
    Czechia Germany Greece Poland

  • Study on Briquilimab for Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Urticaria chronic
    Investigated Drugs:
    • Adrenaline Tartrate Ph. Eur.
    • Briquilimab
    Germany

  • Study on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Ep262
    Germany The Netherlands Poland Spain

  • Study on the Effects of Tiotropium Bromide Gel for Patients with Severe Hand Sweating

    Not recruiting

    2 1
    Investigated Diseases:
    • Hyperhidrosis
    Investigated Drugs:
    • Tiotropium Bromide Monohydrate
    Spain

  • Study on Filgotinib for Children and Teens with Juvenile Idiopathic Arthritis

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Filgotinib
    France Germany Poland Spain

  • Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

    Not recruiting

    3 1
    Investigated Diseases:
    • Neurodermatitis
    Investigated Drugs:
    • Ruxolitinib
    Austria Bulgaria Denmark France Germany Italy +2
Previous Page
1 … 56 57 58 59 60 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!